Shin Nippon Biomedical Laboratories : Another Ophthalmologist
May 08, 2018 at 07:40 am EDT
Share
We are pleased to announce that Kengo Nishi has been awarded a diploma from the Japanese Society of Comparative and Veterinary Ophthalmology. Kengo is now a diplomate of the Japanese College of Fundamental Ophthalmologists.
Ocular toxicology is a burgeoning field and SNBL Japan is committed to having the right equipment and the right people to evaluate ocular toxicology. Kengo is the second diplomate of the Japanese College of Fundamental Ophthalmologists at SNBL Japan, and his skills will add to our safety assessment program. We look forward to seeing him use his skills in future.
Attachments
Original document
Permalink
Disclaimer
Shin Nippon Biomedical Laboratories Ltd. published this content on 08 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 08 May 2018 11:39:19 UTC
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.